Checked.be · Company dossierhttps://checked.be/en/c/apotheek-inge-vermeiren-0808718692 · as of 21-11-2026
APOTHEEK INGE VERMEIREN
ActivePrivate limited company · founded 2008 · active for 17 yearsZeelaan 287, 8670 KoksijdeKBO/BCE: BE 0808.718.692subsidiary of Hidden nameVisible after signing in
Save to list
With a free account you keep companies in your own lists to find and compare them later.
Ten of the last ten came late. The 2019 accounts came in latest, 34 days after the end of the period.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 10,916 companies had the same profile as APOTHEEK INGE VERMEIREN has now. Each dot stands for 28 companies, two years later.
95.1%
were still trading
4.1%
stopped another way
0.7%
went bankrupt
Micro
10 to 20 years old
solvency 30% or more
a profit under 5% of the balance sheet
Test of the method
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,916 companies, not a prediction for APOTHEEK INGE VERMEIREN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Board and ownership
Hidden nameVisible after signing in
Director, Name after signing inVisible after signing in
Name hiddenVisible after signing in 99.96%score XXVisible after signing inequity €449,274 (2025) · annual accounts 2025 of Name after signing inVisible after signing in
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0808718692
Company renamed from APOTHEEK ANNE SAELEN to APOTHEEK INGE VERMEIRENName after signing inVisible after signing in changes role from manager to director · Name hiddenVisible after signing in resigns as statutory manager · Hidden nameVisible after signing in acts as permanent representative · General meeting of 25-11-2019 · Gazette deed
New managerName after signing inVisible after signing in appointed, Name hiddenVisible after signing in resigned · Hidden nameVisible after signing in acts as permanent representative · General meeting of 31-05-2019 · Gazette deed
Capital decrease of €251,400 to €18,600
The capital fell from €270,000 to €18,600 · General meeting of 22-06-2015 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as APOTHEEK INGE VERMEIREN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €457,000 and €688,000, founded between 2006 and 2009.
What is the company number of APOTHEEK INGE VERMEIREN?
The company number of APOTHEEK INGE VERMEIREN is 0808.718.692. The VAT number is the same number with BE in front: BE 0808.718.692.
Where is APOTHEEK INGE VERMEIREN based?
The registered office is at Zeelaan 287, 8670 Koksijde.Company details
What does APOTHEEK INGE VERMEIREN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK INGE VERMEIREN?
APOTHEEK INGE VERMEIREN is a private limited company (BV).
When was APOTHEEK INGE VERMEIREN founded?
APOTHEEK INGE VERMEIREN was founded on 26-12-2008.
Is APOTHEEK INGE VERMEIREN still active?
Yes, APOTHEEK INGE VERMEIREN is an active enterprise in the KBO register.
How many employees does APOTHEEK INGE VERMEIREN have?
APOTHEEK INGE VERMEIREN had an average of 1.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK INGE VERMEIREN?
The turnover in financial year 2025 is about €760,000. This figure is estimated from the gross margin of €161,649 and 43 comparable companies (NACE 477). It probably lies between €500,000 and €1.6m.
Is APOTHEEK INGE VERMEIREN profitable?
In financial year 2025, APOTHEEK INGE VERMEIREN made a profit of €6,441.
Where can I find the annual accounts of APOTHEEK INGE VERMEIREN?
APOTHEEK INGE VERMEIREN filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK INGE VERMEIREN due?
APOTHEEK INGE VERMEIREN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline